Provided by Tiger Trade Technology Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

366.73
-5.7600-1.55%
Post-market: 366.730.00000.00%19:30 EDT
Volume:341.59K
Turnover:125.25M
Market Cap:41.81B
PE:65.61
High:372.00
Open:369.13
Low:364.73
Close:372.49
52wk High:385.22
52wk Low:253.95
Shares:114.00M
Float Shares:85.69M
Volume Ratio:1.26
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.59
EPS(LYR):2.47
ROE:14.66%
ROA:7.46%
PB:8.08
PE(LYR):148.47

Loading ...

Beone Medicines' First-Half Profit Surges 386% as Core Drug Drives Revenue Past $3.2 Billion

Deep News
·
Aug 26

BEONE MEDICINES Reports Strong First-Half Profit Surge of 385.8%

Stock News
·
Aug 26

BeOne Medicines' Tacabrutideg Presents 'Sizable Opportunity' in CSU, RBC Says

MT Newswires Live
·
Aug 25

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

TIPRANKS
·
Aug 25

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)

TIPRANKS
·
Aug 25

BeOne Medicines (ONC), What Is Behind The Fresh Attention Now?

Simply Wall St.
·
Aug 19

BeOne Medicines, Foundations Renew Deal to Deliver Cancer Medicine to Poor Countries

MT Newswires Live
·
Aug 18

Beone Medicines Rises 1.34% With H1 Revenue Reaching 22.2 Billion Yuan as Global Expansion Accelerates

Deep News
·
Aug 18

BeOne Medicines renews partnerships to expand access to Brukinsa in leukemia

TIPRANKS
·
Aug 18

BeOne Medicines (ONC) Secures Rights To Four RAS(ON) Inhibitors In Asia

Simply Wall St.
·
Aug 15

JPMorgan Chase & Co. Increases Stake in BEONE MEDICINES by Over 4.1 Million Shares at Approximately HKD 219.79 Each

Stock News
·
Aug 14

Beone Medicines Awards Over 40,000 Restricted Stock Units to Employees

Stock News
·
Aug 13

Pharmaceutical Rally Continues: Gan&Lee Pharmaceuticals Hits Limit-Up, Beone Medicines Logs 6-Day Winning Streak; Huabao Funds' HK Medical and Innovation Drug ETFs Rise for Third Consecutive Session

Deep News
·
Aug 11

Beone Medicines : Jefferies Raises Target Price to $395 from $388

THOMSON REUTERS
·
Aug 11

CICC Retains Outperform Rating on BeiGene (06160) with HKD 266 Price Target

Stock News
·
Aug 11

BEONE MEDICINES Surges Over 4% in Morning Trading on Strategic Partnership with Revolution Medicines to Accelerate RAS Drug Development

Stock News
·
Aug 11

BeOne Medicines partners with Revolution Medicines for clinical development

TIPRANKS
·
Aug 10

BOCOM International Lifts BEONE MEDICINES Price Target to HKD 276, Maintains Buy Rating

Stock News
·
Aug 10

Goldman Sachs Competitor Adjusts BeOne Medicines Target Upward, Bullish Ratings Maintained

Deep News
·
Aug 09

BEONE MEDICINES Confirms External CMO Supply for Baiyueda, All Processes On Schedule

Deep News
·
Aug 07